TA
LGND icon

Tiedemann Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Tiedemann Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,122
Closed -$326K – 284
2017
Q3 		$326K Buy
+5,122
New +$326K 0.03% 270